Do β-adrenoreceptor blocking drugs associate with reduced risk of symptomatic osteoarthritis and total joint replacement in the general population? A primary care-based, prospective cohort study using the Clinical Practice Research Datalink

INTRODUCTION: To investigate if β-adrenoreceptor blocking drug (β-blocker) prescription reduces the risk of knee or hip osteoarthritis, total joint replacement and analgesic prescription. SETTING: Primary care. METHODS AND ANALYSIS: This is a cohort study using data from the Clinical Practice Resear...

Descripción completa

Detalles Bibliográficos
Autores principales: Nakafero, Georgina, Grainge, Matthew, Valdes, Ana, Townsend, Nick, Mallen, Christian, Zhang, Weiya, Doherty, Michael, Mamas, Mamas A, Abhishek, Abhishek
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2019
Materias:
Rheumatology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6688671/
https://www.ncbi.nlm.nih.gov/pubmed/31375622
http://dx.doi.org/10.1136/bmjopen-2019-032050

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6688671/
https://www.ncbi.nlm.nih.gov/pubmed/31375622
http://dx.doi.org/10.1136/bmjopen-2019-032050

Ejemplares similares